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Abstract.
The prison population are central to the campaign to eliminate hepatitis C virus as a public health 
threat. In the UK this has led to the introduction of a national ‘opt-out’ policy, requiring people in 
prison to be tested for HCV unless they decline, with a target to test 75% of those admitted. 
However, in a representative prison estate in the East Midlands of England (20,000 prison entrants 
per annum) testing rates were only 13.4%. This qualitative study explains why the rates of test 
uptake are so far short of target. This qualitative study examines the experiences of 45 people in 
prison about hepatitis C virus testing in an English category C (low security) prison. The data 
collection method was semi-structured interviews. The data were coded and analysed according to 
the research questions and interpretation of the data was aided by the use of a thematic network 
approach. The themes Fear, Insufficient Knowledge, Stigma, Privacy, Choice and Prison Life 
emerged as the principal barriers to test uptake. Test Uptake Facilitators that promoted testing 
were identified by participants and benefits presented of prison healthcare being a Health Farm.  
In order to increase hepatitis C virus test uptake significant changes and flexibility in the timing, 
location, and staff deployed to test are required. Providing information to people in prison about 
hepatitis C virus transmission and treatment may reduce fears and enable the test uptake target to 
be met and sustained. 
Key Words: Hepatitis C, prisons, opt-out testing, dried blood spot tests, qualitative
Introduction
The public health burden of end-stage liver disease attributable to hepatitis C virus (HCV) 
infection has prompted the World Health Organisation’s call to eliminate HCV by 2030 1. In the 
UK, the National Health Service has escalated this target to be achieved by 2025 2. An effective 
elimination campaign is however critically dependent on a robust mechanism to test those at risk 
and identify people previously undiagnosed. Increasing attention is turning towards the prison 
population due to the high concentration of people sentenced for drug related crimes who may 
have been exposed to HCV. A Health and Justice Report 3 found that in 2014 blood-borne virus 
(BBV) seropositivity in prisons in England and Wales was 1.5% for hepatitis B virus (HBV), 8% 
for HCV and 0.6% for human immunodeficiency virus (HIV). A more recent European review 
estimated that 15.4% of people in prison (PIP)  are infected with HCV in contrast to a prevalence 
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However in 2013, only 7.8% of (16,309/208,552) individuals entering prisons in England and 
Wales were tested for BBVs 5.  In response to these low levels of testing, a  commissioning 
agreement between the National Health Service, Public Health and the National Offender 
Management Service 6 instigated a national opt-out approach to testing in April 2014 with the aim 
of increasing testing rates. An opt-out approach comprises testing people routinely on admission to 
prison unless they specifically decline, in contrast to the previous opt-in approach whereby people 
were asked if they wished to be tested  (Basu et al., 2005). A target has been set to test 75% of 
people entering prisons for BBVs 8. However, in a representative prison estate in the East 
Midlands of England (20,000 prison entrants per annum) between July 2016 and  June 2017, 
implementation of this policy resulted in testing rates of only 13.5% (median 16.6%, range 7.6% 
to 40.7%) (Jack et al., 2019). Whilst this figure shows an encouraging increase it remains that the 
majority of people in prison (PIP) do not access health screening for BBV. Therefore, achieving 
the goal of HCV micro-elimination of HCV in prisons remains an on-going challenge. Against this 
background, this paper presents findings from a qualitative study which aimed to explore the 
reasons why PIP opt-out of HCV testing.
Methods
Study design
This research forms part of a larger mixed methods study evaluating the impact of the opt-out 
approach to HCV testing in prisons. Data from the first stage detailing the changes to test uptake 
and the influential prison operational characteristics has been published elsewhere 9. This 
qualitative study explored the responses of PIP to an opt-out blood-borne virus screening 
programme seeking to identify and treat people infected with HCV and is analysed thematically. 
The lead author (KJ) conducted all interviews which were semi-structured, shaped by a topic 
guide but also guided by participants’ responses. Participants were asked about their views and 
direct experiences of the test intervention; previous test experiences and current test practices; 
knowledge and awareness of HCV viruses, transmission risks and treatments; felt and perceived 
barriers and facilitators to BBV testing. Following each interview, the lead author delivered a brief 
intervention explaining the risk factors for HCV infection, that the test is a dried blood spot, and that new 
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Sample
A category C male prison in the East Midlands, housing a representative group of approximately 
1000 sentenced men, was selected for the study. This prison has a yearly intake of approximately 
1800 men who are nearing the end of their sentence and preparing for resettlement on release. A 
breakdown of the PIP’s ethnicity is: white 75%; Black 11%, Mixed Race 7% and Asian 7% .10 At 
the time of the research, the men entering prison were asked on arrival if they would like a test for 
blood-borne viruses via an opt-out approach and an appointment subsequently booked for a dried 
blood spot test. 45 participants were recruited by the lead author (who is employed by the hospital 
team who provide in-reach HCV treatment) using a purposeful sampling strategy to ensure that 
people with a full range of experiences were interviewed. 16 PIP who were invited to participate 
in the study refused without supplying a reason. Interviews commenced after participants gave 
written informed consent and, with their permission, were audio-recorded. 
Data Analysis
All the participant interviews were transcribed by the lead author (KJ) and organised within 
NVivo software prior to analysis aided by a thematic network 11. Data saturation was achieved. 
The coding of the findings was undertaken by the lead author (KJ) and independently checked and 
scrutinised by the 2nd author. The coding and themes were found to have construct and face 
validity. Initial emergent (inductive) codes were added to a coding framework along with a-priori 
(deductive) codes. Initial coding examined both a priori interests as well as inductive codes 
grounded in the study data. Secondary-level thematic coding was later conducted across the full 
dataset to further fracture the data and allow for the development of conceptually driven 
categories. 
Ethics
Ethical approval was obtained from all required bodies; West Midlands-South Birmingham NHS 
Research Ethics Committee [17/WM/0312], East Midlands National Offender Management 
Service Ethics Committee, the Health Research Authority, Nottinghamshire Healthcare NHS Trust 
and final approval to proceed from the prison Governor.  All participants had the opportunity to 
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Findings.
Interviews lasted mostly between 15 and 45 minutes (range 7-73 minutes). Of the sample, fifteen 
men had refused HCV tests in prisons, whilst the remaining had been tested in a prison with 15 
being HCV RNA positive and 15 being HCV negative. The ages of the PIP ranged between 21 and 
58 years (mean 35 years). The length of time spent in the current prison varied between having 
just arrived and 36 months (mean 5 months). The number of prisons stayed in during their current 
sentence ranged from two to nine (mean 3 prisons) therefore PIP will have been offered HCV 
screening on arrival at each of these establishments. Thus, the population sampled were 
representative of a wide range of ages and experience of prison life, including the admission 
process. 
Our study findings report on the perceptions and experiences of PIP in response to the 
implementation of an opt-out BBV test intervention in an English prison setting. Eight distinct 
thematic networks were contained in the data; Privacy, Stigma, Fear, Insufficient Knowledge, 
Choice and Prison Life have emerged as the principal barriers to test uptake, whilst Test Uptake 
Facilitators were however positively identified by participants and a positive notion presented of 
prison healthcare being a Health Farm. Whilst these themes are reported on separately, they did at 
times over-lap. 
Privacy
This theme encapsulates prisoners’ struggles to deal with a lack of privacy when being screened. 
The location where testing was carried out was important to many PIP. In the majority of prisons, 
testing is undertaken in the healthcare departments and this was considered to be the most private 
environment, because an alternative reason for attending other than an HCV test can be given to 
other PIP ;
“I think the main healthcare. Probably at the same time when people are doing 
other tests, you know. So it can be purely for the reason that it can be explained,
you know, or it can be easily shoved off “  (Participant #22 tested positive)
Whilst the importance of location in the prison was highlighted, more weight was attributed to the 
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“If people know that hepatitis testing is done on a Wednesday, and someone says “oh what 
are you doing here”, but on a Wednesday, it’s straight away hep, so the fact that it’s a 
specific nurse and a specific test on that day”    (Participant #6 tested negative)
The opt-out policy’s intention to test people on arrival at prison was viewed by many PIP as a 
good solution to ensuring privacy was maintained, with typical responses such as;
 “You have to see healthcare anyway when you come in, I don’t know why they don’t offer 
it there and then when you first come in”   (Participant #15 tested positive)
The desire for privacy extended beyond simply having confidentiality maintained by staff, but to 
the wider context of rejecting social contexts where actions could imply they were infected with 
HCV. 
Stigma
Closely related to Privacy is Stigma. This theme captured participants’ intense feelings of 
discontentedness and stigma towards HCV infection, for example; 
 “I know for a fact if I was a prisoner and they put someone in with me…and I knew that 
he had hep C, he wouldn’t be coming through the door. It’s nothing against the man, and 
I’m not going to judge the way he’d lived his life, but you wouldn’t want to put a loaded 
gun in your mouth would you?” (Participant #20 tested negative)
And;
“Yeah, , it’s difficult because you have to stay away from them like…..people avoid them, 
they do get treated different, people that know they’ve got hep C like, when smoking was 
involved, smoking in jail, people won’t share fags with them, or share a drink” 
(Participant #28 refused testing)
Many participants who were HCV positive corroborated these opinions with their own experiences 
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“It’s like there’s an association of being dirty attached to it, and you know people’ll say 
‘oh he’s got hepatitis C’, and ‘don’t go nowhere near him’” 
(Participant #22 tested positive)
The subsequent enacted stigma experienced by some was quite profound, for example;
“I told one person, he kept to himself, but then I got into a fight and I was bleeding, so I 
had to tell somebody else who was trying to help me, then it got round, and then a lot of the 
Muslim brothers thought I had a disease, that just breathing my air would give them the 
disease, they were crossing over from the walkway , not walking the same way, you know it 
was a horrible feeling, I really felt like I was an alien, like I wasn’t part of this world” 
(Participant #32 tested positive)
The origins of the stigma in prisons were rooted in its’ association with injecting drug use, for 
example;
“It’s like a lot of people with hep C are (drug) users, and using (drug taking) is looked 
down on, frowned upon, so that’s probably I think, bit of a stigma attached to it, do you 
know what I mean?”(Participant #30 refused testing)
Fear
Underpinning the stigmatisation of others was the Fear of contracting HCV infection;
“They might pass it on to them, it’s like AIDS, when AIDS first come out, people thought 
they can’t share a cup with someone, can’t touch them, you can’t be near them…..it’s a 
threat to me”  (Participant #32 refused testing)
Being fearful of a positive HCV test result was common too and identified by PIP as rationale for 
not accepting a test, for example;
“People are scared, what they don’t know don’t hurt them. If you told me I’ve got cancer 
I’m going to worry for months until I do pop off, that’s going to be more torture to me than 
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The concerns about a positive HCV diagnosis were linked to a lack of understanding of the 
consequences of infection, worries about the potential associated disease, and a lack of awareness 
about the new curative drug treatments. Typical examples of response included; 
“They don’t want to know, because the fear factor, for them, they’ve got a life altering 
disease that can take their life, and then having to go out there and say to all their mates: 
“we’ve been doing drugs and that, you lot need to get a hep C test because I’ve got hep 
C”, because they know they’re going to get chucked in the whatsit, their cell, with all these 
guys, “you’ve known you’ve had hep C and you’ve not told us”, you know what I mean?” (Participant #35 tested positive) 
These fears of a positive HCV test result were woven in with further concerns about transmitting 
HCV to others, 
 “I was so scared, I was frightened, I didn’t really understand what she said to me, I felt 
very apprehensive about telling my partner, very scared for my daughter who hadn’t been 
born by then, and I was very, very upset that I could have put her and her Mum through it 
as well”  (Participant #24 tested positive)
In addition, many participants indicated how a fear of being found out that they had HCV led to a 
fear of rejection by others, with this notion connecting also to Privacy and Stigma. 
 “They’d probably try and get you off the wing” (Participant #8 tested positive)
The emotion of Fear was also associated with the process of blood testing; 
“I’m scared of needles, if you’re going to want a blood sample, I’m not willing to provide”  (Participant #28 refused testing)
Knowledge
The fear and stigmatising behaviours expressed were provoked by a lack of understanding and 
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“In (different prison), we pack cereal packs with tea bags in, and he’s got hepatitis and 
making people’s cereal packs with no gloves on, if he gets blood in a tea bag or whatever 
then then someone else could contract it” (Participant #29 refused testing)
And;
“In my last prison there was a guy serving people food who had hepatitis and I didn’t 
know this until someone said “I don’t want that guy in here, you got hepatitis” and I was 
like, I don’t think he can work on the server, how is he serving me my food if he’s got 
hepatitis?”   (Participant #2 refused testing)
A surprisingly high number of PIP believed that HCV infection can be transmitted by sharing 
electronic cigarettes and one participant indicated the possible source of this mis-information;
“If you can catch it by sharing a crack pipe, if someone passes you a cigarette and they’ve 
got blood on the end of the cigarette, you can catch it can’t you? So it’s not just through a 
dirty way of catching it, you can catch it in a lot of ways” 
(Participant #44 tested negative)
Furthermore, whilst the majority of PIP were aware about HCV, there were a small number of PIP 
whose knowledge was non-existent;
“I don’t even know what hepatitis is.  Never heard of it before, people can catch it from 
having sex in prison I guess? “
(Participant #18 refused testing)
Choice
The deprivation of liberty associated with a prison sentence means that any opportunity to exercise 
choice and challenge the system is an important feature of prison life. Illustrations of this 
standpoint include;
 “It’s a unique kind of community in prison, it’s got little sections, rules, quirks and that, 
but that stems from  choice, you know, because prisoners who are restricted behave in a 
way , people resist against compulsory things, and if it’s their choice they’ll  do it more” 
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And;
“It’s (healthcare) the only freedom that we’ve got. Something like that (BBV test) if it’s an 
option, and you’re trying to force it onto somebody, some of them will just go against it 
just for the sake of going against it, anti-establishment”
(Participant #20 tested negative)
Emphatic views were expressed stated which emphasised the importance of choice, for example;
“It’s an invasive process isn’t it, and anything that’s an assault basically, it’s got to be a 
choice” (Participant #6 tested negative)
An individual’s perception of their risk of acquiring HCV infection clearly plays a role when 
choosing to accept a test, particularly when being moved to other prisons;
“I wouldn’t need it (another test), because I don’t do nothing, I’m drug free now so I don’t 
share nothing, I don’t do nothing, chances of getting it are very slim” 
(Participant #44 tested negative)
Decisions were also made about whether it was safe to leave the prison wing and attend 
appointments in the healthcare department, for example;
“If people take drugs and they’re in debt from other wings, you can’t go to healthcare and 
simply bump into people that they don’t want to see because they’ll get their head smashed 
in” (Participant #29 refused testing)
Prison Life
Possibly the biggest barrier to getting tested was prison life itself which was depicted principally 
as harsh. Barriers to meeting health needs were an intrinsic feature resulting from the prison’s 
culture, security and rehabilitation regime. For example, insufficient numbers of nurses were 
reported;
“I mean these poor guys they’re run ragged as it is, the healthcare team here, They’ve got 
to multitask all the time, they’ve got people at them all the time for this that and 
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(Participant #12 tested positive)
Additionally the lack of prison officers to escort people to the healthcare clinic was observed;
“It’s the logistics of moving about the jail with officers, so like in here if you’ve got a 
healthcare appointment you can just walk down there, it’s a bit more relaxed, some cat Bs 
it’s not, so if that officer’s busy and they haven’t got the staff to do that stuff all the time, 
it’s hard isn’t it?” 
(Participant #43 tested negative)
The timing of the test was frequently commented on, with a variety of views expressed that 
indicates the need for multiple occasions and locations;
 “You’ll probably find people more receptive a month later once they’ve settled in, got into 
their stride, it’s bad enough having to land here as it is and going through the whole 
induction process, you’ve got a lot on your plate anyway, thinking “oh who have I got to 
share with, who got to do this with” (Participant #12 positive)
And;
“People are lazy, especially in healthcare, for them to have an appointment, especially if 
it’s raining…”I ain’t walking over there, and getting soaking wet”, so do it (test) when 
they first come in, then you’d get everyone” 
(Participant #16 tested positive)
And; 
“A waste of time in a cat B (remand prison) because don’t know if they’re coming or 
going, by the time they get the results they could be out. It’s probably better when they are 
in a C cat (sentenced prisoners)”
(Participant #28 refused testing)
Some PIP were concerned that the prison officers could deduce the reason for attendance and that 
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“If I were to go up there, even though the officers not taking me into the consulting room, 
if the officer gets to know what the appointment is, that would be a problem”  
(Participant #27 tested positive)
Nonetheless the majority of PIP felt that a prison officer escort would not dissuade them from 
attending, for example;
“No, because a member of staff’s not going to be in there while you have it done, they wait 
outside. It’s only going to be you and that health worker what’s there”
 (Participant #19 refused testing)
Furthermore, it is common practice for PIP to be contacted only if their BBV test result is positive. 
Not receiving confirmation of a negative result and considerable delays with receiving a positive 
test result were common sources of disgruntlement and discouraged repeat testing; 
 “Yeah, not knowing, and not getting the results. To be behind your door, locked up all the 
time and have that on your mind, have I got something, have I not got it? That’s a lot of 
stress that someone don’t need, and I think that’ll put a lot of people off” 
(Participant #44 tested negative)
Health Uptake Facilitators
A variety of ideas emerged from the interviews about ways to increase testing and these can be 
divided into two groups, Education and Procedural. Firstly, increasing opportunities for health 
education about HCV transmission and treatment were considered important; 
“Maybe give out hep C information packages, booklets, as part of the induction pack or 
something, put a few more posters up about it in healthcare, you can be there an hour and 
a half sometimes, people always end up reading what’s on the wall”
 (Participant #12 tested positive)
There was strong appetite for the notion of peer-led support and education, for example;
 “Have somebody that’s actually got hepatitis or HIV sitting in, how its affected their life 
to have HIV or hepatitis, that will probably help the prisoner decide if he wants it or not.  
Explain it prisoner to prisoner, it could make him feel a lot more comfortable”  
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Secondly, the procedural suggestions focussed on working flexibly and creatively;
 “At (another prison) they actually come on the wing, a lot more people sitting down 
having it done, think most of the wing were done to be honest, that’s how I’d do it” 
(Participant #15 tested positive)
And;
“If you say, look its 3 words, “we’re testing everybody”, and you have to sign a form if 
you don’t want to do it, people will just do it” (Participant #17 refused testing)
The theory that an opt-out testing procedure would normalise the process was evident;
“They’ll think, ‘well everyone’s getting it done, I’ll get it done’, more than singling certain 
people out. If they think everyone’s getting it done it’s like it’s a bit of the norm isn’t it?” (Participant #44 tested negative)
However many PIP felt that this wasn’t a robust enough approach; 
“I think it should be mandatory,” (Participant #37 tested negative)
Furthermore, the dried blood spot test was viewed by the majority as a highly preferable 
alternative to venepuncture;
“The fingerprick is good because a lot of people who use drugs intravenously it’s hard to 
get themselves, so there is a lot of fear, you know, “oh you’re not going to get me” and 
stuff like this, and  that puts up a barrier straight away. With the needleprick there’s no 
barriers, it’s just like having a diabetes test or whatever” (Participant #35 tested positive)
Health farm
This final theme groups the extracts from interviews which highlights that many PIP use the 
opportunity of incarceration to address health needs. 
“I call it the health farm. To be honest with you without this place I think I’d have been 









This article is protected by copyright. All rights reserved
And;
 “Nurses are more like Mummies, they’re like Nanna’s, you go see a nurse and you know 
you’re getting alright” (Participant #39 tested negative)
The opportunity for a check-up by a nurse on arrival at prison was appreciated by some PIP; 
“It’s like a MoT Miss, it’s nice when you come into a prison and they ask you all these 
things, to help you for when you get out” (Participant #5 tested negative)
Furthermore, prison was described by many who were HCV positive as a good environment in 
which to receive antiviral therapy, for example;
“Probably because in prison you’ve got a lot of spare time on your hands, and it’s an ideal 
place to have treatment like this rather than outside, life outside is very, you’re a lot more 
going on that what you would if you was inside, if you’ve got kids, the missus or whatever, 
family issues, so being in prison you know you’ve got a lot of time, spare time” (Participant #22 tested positive)
However receiving a diagnosis of HCV in prison was clearly an inconsolable experience for some 
PIP, 
“It just smashed my world, I were crying, I weren’t expecting, tears rolling down 
my eyes…it was worser than finding my Mum dead” 
(Participant #35 tested positive)
These excerpts illustrate that there are a sub-group of PIP who are willing to spend time in prison 
constructively addressing actual or potential diagnosis which could be harnessed regarding BBV 
screening. 
Discussion
There is a paucity of published studies presenting the process and utility of opt-out screening 
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look at the lived experience of PIP and why they may not take up the offer of BBV screening in 
custodial establishments.
Taken together the themes underscore the complexities in prison regarding accessing health 
screening and communication about risk of future disease. The emergent leitmotif is Fear and this 
strong emotion expressed is the hidden layer where PIP related barriers to testing reside. There 
were multiple expressions of fears which discouraged test uptake; of acquiring HCV in prison, of a 
positive diagnosis, of being found out if infected and excluded from other PIP, of needles used for 
blood testing, and the anxiety of waiting for the test result which was provided only for those 
testing positive. The dried blood spot test results can take up to four weeks to be returned because 
the tests are sent in batches to the laboratory and this delay compounds PIP’s worries. Fear of a 
positive diagnosis has been observed by other authors exploring HCV testing 12–17 and needle-
phobia amongst PWID has been frequently reported 16,18,19. A fear of disclosure of being HCV 
positive has been noted too by several authors 12,14–16.
These anxieties were all woven into additional themes. It was expected by the researchers that 
confidentiality would be raised as an important need by the PIP because this has been widely 
acknowledged in this patient population 15,20. However Privacy, which applies to the person and 
includes their right to be concealed from other’s views or intrusion, illustrates the importance of 
also minimising environmental cues  from which other PIP may deduce a diagnosis. Therefore 
designated clinics for BBV testing or treatment, whilst arguably easier for staff to manage, were 
less popular amongst the participants interviewed and discouraged attendance amongst some 
participants. 
Stigma was an expected theme as it is widely reported in the literature discussing HCV 15,21,22. 
Specifically, HCV related stigma is associated with IDU 15,22,23  so this too was an a-priori 
observation. There was evidence of both felt stigma (associated with being infected) and enacted 
stigma (episodes of discrimination) 24 in the interviews. It is argued that “stigma is entirely 
dependent on social, economic and political power because it takes power to stigmatise25. The 
people who might stigmatize in an environment or situation may be asked if they have the 
following powers to: ensure that the human difference they recognize and label is broadly 
identified in the culture; ensure that the culture recognizes and deeply accepts the stereotypes they 
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control access to major life domains like educational institutions, jobs, housing, and health care in 
order to insert consequential teeth into the distinctions they draw25. If the answers are yes, as they 
will be in prisons, then stigma is to be expected. Therefore whilst the notion of increasing 
knowledge to PIP and all relevant stakeholders regarding HCV may be considered a means of 
resolving stigma, this approach fails to recognise that firstly many types of stigma are embedded 
in the prison culture26 and secondly it is unlikely to change the PIP’s felt stigma which is based on 
their prior experiences27. 
However, it is still necessary to introduce information to PIP and prison officers about the need to 
test for HCV so that people infected can be identified and treated. One emerging intervention 
showing success is the creation of prison peer educators specifically for HCV. Peer support in 
prisons is an established feature in England and Wales, for example the Listeners service created 
by the Samaritans to offer emotional support, and peer work offering advice with housing, 
language translation and supporting healthcare in general 28. Benefits observed are that peer 
support is highly acceptable in prisons, there are reductions in risky behaviours, and both practical 
and emotional support are provided28. The Health and Justice Prison Peer Project was launched in 
England during 2017 29 to  deliver peer-led training and one-to-one support in order to encourage 
the uptake of HCV testing and treatment if required. A study in Eire30evaluated the role of prison 
peer educators to create educational material for the prison and undertake peer supported HCV 
screening and links to treatment. Over the course of six days, 425 PIP were tested, 12% (50/425) 
found to be HCV RNA positive of whom 43 were linked to a hospital based treatment service.  
Low levels of Knowledge means that PIP are not sufficiently well informed to understand if they 
are at risk of HCV or not and this is leading to missed opportunities of testing people genuinely at 
risk. Poor levels of knowledge amongst PIP surrounding modes of transmission have been noted 
by other authors15,21,31 .Whilst increasing PIP’s knowledge is important to encourage test uptake, it 
is also possible that accurate information about HCV transmission may lead to PIP opting-out of 
testing if they accurately self-assess that they are not at risk of having acquired HCV infection.
Exercising Choice regarding healthcare emerged as being hugely important to the PIP in a context 
where liberty and freedom to choose are restricted.PIP are often referred to as being a “captive 
audience” 32 but the data shows this is not necessarily true. Whilst PIP are held captive, they are 
not automatically interested and engaged in preventative health measures and several participants 
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observed too by prison officers in a previous study23 and further illustrates the needed for skilled 
communicators to encourage PIP to be tested. 
One feature of Prison Life is that healthcare is a commissioned element, not the sole raison d’etre 
as it is in designated primary, secondary or tertiary healthcare settings. Prisons’ core focus is on 
punishment, offender rehabilitation and maintaining a safe environment and is achieved by 
enforcing a strict regime of daily activities, which results in limited flexibility for non-urgent 
healthcare delivery. This contributes to PIP not being given negative BBV test results, along with 
associated health education and harm reduction advice, because there are insufficient healthcare 
appointments available to facilitate this.  Maintaining a safe environment is also one of the 12 
activities of daily living underpinning nursing care 33. In the context of BBV testing it applies to 
maintaining both individual patient safety by eliminating an infection that can lead to liver disease, 
and to maintaining prison safety by reducing the pool of infection that could be transmitted to 
other PIP or staff.  This is perhaps the shared goal that could enable increased engagement and 
support from prisons and facilitate the delivery of a HCV micro-elimination strategy. It is in the 
prison staffs’ interest for BBVs to be eliminated given the altercations that require intervention 
and subsequent anxiety experienced by the prison officers who have been exposed to body fluids 
23.
Many of the PIP interviewed spoke very warmly about the nurses and appreciated their time in the 
Health Farm where prison nurses are required to practice at the top of their professional ability as 
physician availability is limited. Supporting prison nurses and understanding the challenges faced 
are the key to a significant increase in testing rates. It is perhaps unreasonable to expect prison 
nurses to facilitate the delivery of an HCV elimination strategy without their inclusion in the 
Hepatitis Operational Delivery Network’s (the English HCV treatment networks) discussions and 
plans. The Test Uptake Facilitators suggested by participants all fall into the jurisdiction of the 
prison nurses’ domain so closer collaboration is essential. A need to provide multiple options of 
test location, timing of test offer, test method and staff allocated to conduct BBV screening is 
evident within the themes. 
This research is not without limitations. The authors acknowledge that the qualitative data 
produced within this particular study context may limit the transferability of the study findings 
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interviewed.  The experiences between people of differing ethnicity were not captured, nor the 
participant’s history of risk factors for HCV infection.
Additional research is required to further understand and quantify the reasons why PIP decline 
HCV testing in order to refine and embed the care pathway into a routine process. 
Conclusion
This is the first study that has recorded interviews with people in prison, to the authors’ 
knowledge, exploring their views about the process of opt-out testing for HCV infection. The data 
presented shows that a single approach to the timing, location and method of testing will not meet 
the needs of a population whose views on the acceptability of being repeatedly screened for BBVs 
in prison are heterogenic. The findings illustrate that Fear is an important driver of Stigma, and 
that Fear in this context is a consequence of insufficient Knowledge. There is thus an urgent need 
to increase the education about HCV transmission and treatment in order to sustainably increase 
the uptake of HCV testing in prisons and achieve micro-elimination in this population. 
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